Caryl and Israel Englander
Institute for Precision Medicine

You are here

what is precision medicine?

News

Latest news from The Englander Institute for Precision Medicine:

 

July 21, 2016
A powerful next-generation genome-sequencing test developed at Weill Cornell Medicine can detect mutations that guide precision cancer treatment with over 95 percent accuracy, according to new research. The scientists say their findings, published July 20 in NPJ Genomic Medicine, validate the test, called Weill Cornell Medicine EXaCT-1, and demonstrate its feasibility in a clinical setting.
July 19, 2016

NEW YORK (CBSNewYork) — Virtual reality is just not for the gaming world as doctors are using it to help treat cancer patients.

CBS2’s Dr. Max Gomez reported the technology allows doctors to get inside a patient's cancer and pinpoint the cause.


July 15, 2016

Researchers from Weill Cornell Medicine have published a paper in the BioRxiv that describes the Precision Medicine Knowledgebase (PMKB), an online platform that offers access to clinical-grade tumor mutations, annotations, and interpretations identified in patient samples. 


July 15, 2016

Qatar now has its own population-specific genome resource after researchers at Weill Cornell Medicine in New York and Qatar mapped the genomes of more than 1,000 Qatari nationals.


July 12, 2016

One of the biggest challenges in precision medicine is what to do with the mountain of data generated from the sequencing of each tumor – how to parse out the relevant information and make it accessible and useful to the physicians making treatment decisions.  Ultimately, such data should be available for a function called Clinical Decision Support.  This function as defined by the Federal Office of the National Coordinator for Health Information Technology is “knowledge and person-speci


Weill Cornell Medicine
Caryl and Israel Englander
Institute for Precision Medicine
413 E 69th Street
Belfer Research Building
New York, NY 10021 Phone: